The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
Open Access
- 6 May 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 12 (1), 251
- https://doi.org/10.1186/s13104-019-4287-z
Abstract
There are three major serologic markers for hepatitis B virus (HBV) infection: hepatitis B surface antigen (HBsAg); hepatitis B surface antibody (anti-HBs); and hepatitis B core antibody (anti-HBc). HBV screening programs, however, often test only HBsAg and anti-HBs, missing those individuals who have anti-HBc as the only detectable marker. Isolated anti-HBc can represent chronic infection in which HBsAg is not detectable by serology. We, therefore, investigated the prevalence of isolated anti-HBc in an ethnic community at moderate to high risk for HBV infection. Of 7157 Korean American adults in New Jersey, 2736 (38.2%) lacked anti-HBs, potentially susceptible to HBV. Of these 2736 subjects, 771 subjects had anti-HBc. The prevalence of isolated anti-HBc increased with age: 0.8% (age 21–30); 2.4% (age 31–40); 6.05% (age 41–50); 11.7% (age 51–60); 18.3% (age 61–70); and 24.5% (age 71–91). Similarly, the percentage of the individuals with isolated anti-HBc in anti-HBs lacking subjects showed a striking age dependence. We conclude that serologic HBV screening should include anti-HBc to accurately assess the prevalence of HBV exposure. Serologic screening with only HBsAg and anti-HBs may overestimate the prevalence of non-immune population. It can also underestimate the prevalence of HBV and increase the risk of HBV reactivation during immunosuppression.Keywords
This publication has 19 references indexed in Scilit:
- Occult hepatitis B virus infectionWorld Journal of Hepatology, 2014
- Management of patients with hepatitis B who require immunosuppressive therapyNature Reviews Gastroenterology & Hepatology, 2013
- Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective studyJournal of Hepatology, 2013
- Low Rates of Hepatitis B Virus Screening at the Onset of ChemotherapyJournal of Oncology Practice, 2012
- Natural History of Chronic Hepatitis BClinics in Liver Disease, 2010
- Epidemiology of hepatitis B in the United StatesJournal of Hepatology, 2009
- Knowledge, Attitudes, and Behaviors of Chinese Hepatitis B Screening and VaccinationAmerican Journal of Health Behavior, 2008
- The Response of Isolated Anti-HBc Positive Subjects to Recombinant Hepatitis B VaccineJournal of Infection, 2001
- Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis BJournal of Hepatology, 1993
- Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implications in hepatitis B vaccination programsJournal of Hepatology, 1988